Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany

Additional treatment options for coronavirus disease (COVID-19) are urgently needed, particularly for populations at high risk of severe disease. This cross-sectional, retrospective study characterized the outcomes of 43 patients with nosocomial severe acute respiratory syndrome coronavirus-2 (SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehler, Johanna, Ritzer, Barbara, Weidlich, Simon, Gebhardt, Friedemann, Kirchhoff, Chlodwig, Gempt, Jens, Querbach, Christiane, Hoffmann, Dieter, Haller, Bernhard, Schmid, Roland M., Schneider, Jochen, Spinner, Christoph D., Iakoubov, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269399/
https://www.ncbi.nlm.nih.gov/pubmed/34244967
http://dx.doi.org/10.1007/s15010-021-01657-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269399/
https://www.ncbi.nlm.nih.gov/pubmed/34244967
http://dx.doi.org/10.1007/s15010-021-01657-y

Ejemplares similares